IMAGINE
Our investigational therapy, VH-550, may help dogs
run, play and live better
Injection into Joint
Injection of the therapeutic agent generates a powerful anti-inflammatory protein localized to the joint
VH-550 May Reduce Inflammation
Decreased inflammation leads to a reduction of pain severity
Improved Mobility and Pain Reduction
Reduced pain can improve mobility and quality of life
Market Size by the Numbers*
137M
Companion Animals in US
#1
Most common joint disease diagnosed in veterinary medicine
$2B+
Global Canine OA Market Opportunity
*AVMA Pet Ownership and Demographics Sourcebook, 2017-2018 edition; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884849/; https://www.expertmarketresearch.com/reports/canine-arthritis-treatment-market
About Vetana Animal Health
Vetana’s mission is to improve animal health. We are a company dedicated to addressing pain and mobility issues in companion animals, including dogs, cats and horses. We are leveraging a robust scientific platform using interleukin-10 (IL-10), nature’s anti-inflammatory. Our research and deep understanding of IL-10 biology is converging with recent technology advancements, notably in non-viral gene therapy platforms. With the development of our IL-10 gene therapies, we are now in a unique position to explore solutions that can be effective, safe and provide longer duration of relief for the millions of companion animals affected by inflammatory diseases such as osteoarthritis, neuropathic pain and countless others.
TESTIMONIALS
CONTACT
Vetana Animal Health, Inc.